Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
Sponsor: Sanofi • ClinicalTrials.gov ID: NCT07038473
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in young children and adolescents who have first degree relatives with T1D. This protocol has been developed to address the growing need for standardized T1D screening, monitoring, and data collection in alignment with international recommendations. The study's estimated duration is 13 months and will consist of two visits: Visit 1 (screening visit) and Visit 2 (confirmatory visit).
Interventions
-
Investigational Procedure
(Procedure)
It consists of prospective blood sample collection from children, adolescents and first-degree relatives of T1D probands. Study without any Investigational Medicinal Product (IMP) administration.
Eligibility criteria
Conditions
Locations
- Dasman Diabetes Institute - Site Number: 08 — Kuwait City, Al Asimah / Capital Governorate, Kuwait
- Imam Abdulrahman Bin Faisal University - Site Number: 05 — Dammam, Eastern Province, Saudi Arabia
- King Abdulaziz Medical City, National Guard Hospital, Jeddah - Site Number: 01 — Jeddah, Mecca Region, Saudi Arabia
- King Fahd Medical City - Site Number: 03 — Riyadh, Saudi Arabia
- King Faisal Specialist Hospital & Research Centre - Site Number: 02 — Riyadh, Saudi Arabia
- Sheikh Khalifa Medical City - Site Number: 07 — Abu Dhabi, United Arab Emirates
- Sheikh Shakhbout Medical City - Site Number: 06 — Abu Dhabi, United Arab Emirates
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record